دورية أكاديمية
Safety, tolerability, pharmacokinetics, and immunogenicity of JMB2002–an antibody against COVID-19: a phase 1 clinical trial in healthy Chinese adults
| العنوان: | Safety, tolerability, pharmacokinetics, and immunogenicity of JMB2002–an antibody against COVID-19: a phase 1 clinical trial in healthy Chinese adults |
|---|---|
| المؤلفون: | Chen, GuilingAff1, Aff2, Zhang, Ying, Wu, Kaiqi, Jin, Tinghan, Peng, Conggao, Jiang, Qi, Tian, Wenjuan, Chen, ZhongAff1, IDs12879023083416_cor8, Shen, ZhenweiAff4, IDs12879023083416_cor9, Sheng, GuopingAff2, IDs12879023083416_cor10 |
| المصدر: | BMC Infectious Diseases. 23(1) |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 14712334 |
|---|---|
| DOI: | 10.1186/s12879-023-08341-6 |